
Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.
Sanjay Rajagopalan, MD, the Herman K. Hellerstein, MD, chair in cardiovascular research at University Hospitals of Cleveland Harrington Heart & Vascular Institute, discusses the link between cardiovascular disease and air pollution and how primary care doctors can help patients lower their risk of cardiovascular disease caused by air pollution.





